Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori

Journal of Drug Targeting

Volumn 16, Issue 1, 2008, Pages 65-72

  Ramteke, Suman ^a   Jain, Narendra ^b  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Clarithromycin; Dual therapy; Gliadin; H. pylori; Nanoparticles; Omeprazole

Indexed keywords

CLARITHROMYCIN; GLIADIN; NANOPARTICLE; OMEPRAZOLE; PHOSPHATE BUFFERED SALINE; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; DRUG ACCUMULATION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG POTENTIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH JUICE; SUSTAINED RELEASE FORMULATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CHEMISTRY, PHARMACEUTICAL; CLARITHROMYCIN; DRUG COMBINATIONS; EXCIPIENTS; GASTRIC MUCOSA; GASTROINTESTINAL TRACT; GLIADIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OMEPRAZOLE; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ADHESIVES;

EID: 38049031666     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701733278     Document Type: Article

References (23)

1. Arangoa, MA, Campareso, MA, Popineau, Y., Trache, JM, Campareso, MA, Popineau, Y. and Ireache, JM (1999) Chromatographia, 50, pp. 243-246.
2. Arangoa, MA, Ponchel, G., Orecchioni, AM, Renedoi, MJ, Duchene, D. and Irache, JM (2000) Eur J Pharm Sci, 11, pp. 333-341.
3. Arangoa, MA, Companero, MA, Renedo, MJ, Ponchel, G. and Irache, JM (2001) Pharm Res, 11, pp. 1521-1527.
4. Bardhan, KD, Dallaire, C., Eisold, H. and Duggan, AE (1997) Gut, 41, pp. 181-186.
5. Blaser, MJ (1992) Gastroenterology, 102, pp. 720-727.
6. Chen, XG, Correa, P. and Offenhause, J. (1986) Am J Clin Pathol, 86, pp. 575-582.
7. Durrer, C., Irache, JM, Puisieux, F., Duchene, D. and Ponchel, G. (1994) Pharm Res, 11, pp. 680-683.
8. Graham, DY and Qureshi, WA (2000) Curr Pharm Des, 6, pp. 1537-1544.
9. Gupta, PK, Leung, SH and Robinson, JR (1990) Bioadhesive drug delivery systems, pp. 65-92. CRC Press, Boca Raton, FL
10. Gustavson, LE, Kaiser, JF, Edmond, AL, Locke, CS, DeBartolo, MI and Schneck, DW (1995) Antimicrob Agents Chemother, 39, pp. 2078-2083.
11. Leunk, RD, Johnson, PT, David, BC, Kraft, WG and Morgan, RD (1998) J Med Microbiol, 26, pp. 93-99.
12. Lovene, MR, Romano, M. and Pilloni, AP (1999) Chemotherapy, 45, pp. 8-14.
13. Medonca, S., Ecclissato, C. and Sartori, MS (2000) Helicobacter, 5, pp. 79-83.
14. Megraud, F. (1997) Aliment Pharmacol Ther, 11, pp. 43-53.
15. Moss, S. and Calam, J. (1992) Gut, 33, pp. 289-292.
16. Parsonnet, J., Friedmam, GD, Vadersteen, DT, Chang, Y., Vogelman, JH and Overtrich, N. (1991) N Engl J Med, 325, pp. 1127-1133.
17. Ramteke, S., Umamaheshwari, RB and Jain, NK (2006) Indian J Pharm Sci, 68, pp. 448-479.
18. Rune, SJ (1994) Scand J Gastroenterol, 29, pp. 45-47.
19. Umamaheshwari, RB and Jain, NK (2003) J Drug Target, 11:7, pp. 415-424.
20. Umamaheshwari, RB, Jain, P. and Jain, NK (2003) STP Pharma Sci, 13:1, pp. 41-48.
21. Umamaheshwari, RB, Jain, S., Bhadra, D. and Jain, NK (2003) J Pharm Pharmacol, 55, pp. 1607-1613.
22. Umamaheshwari, RB, Jain, S. and Jain, NK (2003) Drug Deliv, 10, pp. 151-160.
23. Umamaheshwari, RB, Ramteke, S. and Jain, NK (2004) AAPS PharmaSciTech, 5:2, pp. 1-9.